ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 2c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.44), $0.02 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Kotak Upgrades JSW Steel Ltd (JSTL:IN) to Buy (1)
• Bernstein SocGen Group Upgrades ICICI Bank (ICICIBC:IN) (IBN) to Outperform